News > China grants country’s first Covid-19 vaccine patent to CanSino
China grants country’s first Covid-19 vaccine patent to CanSino
The Hindu Business Line | 17/08/2020 01:55 PM | Click to read full article
China’s vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its Covid-19 vaccine candidate Ad5-nCOV.
It is the first Covid-19 vaccine patent granted by China. Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. CanSino has said it is also in talks with Russia, Brazil, and Chile to launch Phase III trials in those countries.